New insider activity at Incyte ( (INCY) ) has taken place on December 3, 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EVP & Chief Medical Officer Steven H Stein recently sold 39,757 shares of Incyte stock, amounting to a total transaction value of $4,068,607.
Spark’s Take on INCY Stock
According to Spark, TipRanks’ AI Analyst, INCY is a Outperform.
Incyte’s strong financial performance and positive earnings call sentiment are the primary drivers of its high score. The company’s robust profitability, minimal leverage, and strategic R&D investments position it well for future growth. Technical indicators suggest bullish momentum, although caution is advised due to overbought signals. The valuation is fair, supporting the company’s growth potential.
To see Spark’s full report on INCY stock, click here.
More about Incyte
YTD Price Performance: 45.89%
Average Trading Volume: 2,128,075
Technical Sentiment Signal: Buy
Current Market Cap: $19.91B